Kari T. Kivistö

1.7k total citations
17 papers, 1.3k citations indexed

About

Kari T. Kivistö is a scholar working on Pharmacology, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Kari T. Kivistö has authored 17 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 6 papers in Surgery and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Kari T. Kivistö's work include Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (5 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Kari T. Kivistö is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (5 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Kari T. Kivistö collaborates with scholars based in Finland and Germany. Kari T. Kivistö's co-authors include Pertti J. Neuvonen, Jari J. Lilja, Teemu Kantola, Janne T. Backman, Tommi Lamberg, Ulrich Klotz, Tiina Varis, Kari Laine, Wen Xia and Päivi Taavitsainen and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Clinical Pharmacokinetics and The Journal of Clinical Pharmacology.

In The Last Decade

Kari T. Kivistö

17 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kari T. Kivistö Finland 15 648 438 291 244 223 17 1.3k
Jari J. Lilja Finland 16 668 1.0× 575 1.3× 225 0.8× 276 1.1× 301 1.3× 20 1.4k
Teemu Kantola Finland 8 538 0.8× 355 0.8× 426 1.5× 191 0.8× 170 0.8× 10 1.2k
Hideki Fujino Japan 20 508 0.8× 579 1.3× 377 1.3× 152 0.6× 149 0.7× 36 1.1k
Bennett Ma United States 16 616 1.0× 467 1.1× 489 1.7× 186 0.8× 172 0.8× 38 1.6k
V W Steinijans Germany 27 345 0.5× 232 0.5× 336 1.2× 395 1.6× 285 1.3× 80 2.3k
Ylva Böttiger Sweden 21 457 0.7× 255 0.6× 298 1.0× 329 1.3× 119 0.5× 53 1.4k
T. Leemann Switzerland 16 871 1.3× 415 0.9× 138 0.5× 159 0.7× 267 1.2× 26 1.3k
Leslie Z. Benet United States 16 308 0.5× 330 0.8× 208 0.7× 277 1.1× 131 0.6× 26 1.0k
John A. Pieper United States 25 951 1.5× 531 1.2× 243 0.8× 290 1.2× 391 1.8× 65 1.9k
Lloyd R. Whitfield United States 19 216 0.3× 325 0.7× 359 1.2× 156 0.6× 102 0.5× 48 1.2k

Countries citing papers authored by Kari T. Kivistö

Since Specialization
Citations

This map shows the geographic impact of Kari T. Kivistö's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari T. Kivistö with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari T. Kivistö more than expected).

Fields of papers citing papers by Kari T. Kivistö

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kari T. Kivistö. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari T. Kivistö. The network helps show where Kari T. Kivistö may publish in the future.

Co-authorship network of co-authors of Kari T. Kivistö

This figure shows the co-authorship network connecting the top 25 collaborators of Kari T. Kivistö. A scholar is included among the top collaborators of Kari T. Kivistö based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kari T. Kivistö. Kari T. Kivistö is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Varis, Tiina, Janne T. Backman, Kari T. Kivistö, & Pertti J. Neuvonen. (2000). Diltiazem and mibefradil increase the plasma concentrations and greatly enhance the adrenal-suppressant effect of oral methylprednisolone. Clinical Pharmacology & Therapeutics. 67(3). 215–221. 29 indexed citations
2.
Lamberg, Tommi, Kari T. Kivistö, & Pertti J. Neuvonen. (1999). Lack of Effect of Terfenadine on the Pharmacokinetics of the CYP3A4 Substrate Buspirone. Pharmacology & Toxicology. 84(4). 165–169. 7 indexed citations
3.
Kivistö, Kari T., Jari J. Lilja, Janne T. Backman, & Pertti J. Neuvonen. (1999). Repeated consumption of grapefruit juice considerably increases plasma concentrations of cisapride. Clinical Pharmacology & Therapeutics. 66(5). 448–453. 53 indexed citations
4.
Kivistö, Kari T., et al.. (1999). The effect of rifampin on the pharmacokinetics of oral and intravenous ondansetron. Clinical Pharmacology & Therapeutics. 65(4). 377–381. 36 indexed citations
5.
Kivistö, Kari T., et al.. (1999). Cytochrome P450?inducing antiepileptics increase the clearance of vincristine in patients with brain tumors. Clinical Pharmacology & Therapeutics. 66(6). 589–593. 64 indexed citations
6.
Xia, Wen, et al.. (1999). Midazolam α‐Hydroxylation by Human Liver Microsomesin vitro: Inhibition by Calcium Channel Blockers, Itraconazole and Ketoconazole. Pharmacology & Toxicology. 85(6). 157–161. 56 indexed citations
7.
Varis, Tiina, Kari T. Kivistö, Janne T. Backman, & Pertti J. Neuvonen. (1999). Itraconazole Decreases the Clearance and Enhances the Effects of Intravenously Administered Methylprednisolone in Healthy Volunteers. Pharmacology & Toxicology. 85(3). 29–32. 36 indexed citations
8.
Lilja, Jari J., Kari T. Kivistö, & Pertti J. Neuvonen. (1999). Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin. Clinical Pharmacology & Therapeutics. 66(2). 118–127. 183 indexed citations
9.
Neuvonen, Pertti J., Jari J. Lilja, & Kari T. Kivistö. (1999). Grapefruit juice increases serum simvastatin and atorvastatin but not pravastatin. Clinical Pharmacology & Therapeutics. 65(2). 180–180. 4 indexed citations
10.
Lilja, Jari J., Kari T. Kivistö, & Pertti J. Neuvonen. (1999). Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin. Clinical Pharmacology & Therapeutics. 66(2). 118–127. 44 indexed citations
11.
Lamberg, Tommi, Kari T. Kivistö, & Pertti J. Neuvonen. (1998). Effects of verapamil and diltiazem on the pharmacokinetics and pharmacodynamics of buspirone*. Clinical Pharmacology & Therapeutics. 63(6). 640–645. 49 indexed citations
12.
Lilja, Jari J., Kari T. Kivistö, Janne T. Backman, Tommi Lamberg, & Pertti J. Neuvonen. (1998). Grapefruit juice substantially increases plasma concentrations of buspirone*. Clinical Pharmacology & Therapeutics. 64(6). 655–660. 91 indexed citations
13.
Kantola, Teemu, Kari T. Kivistö, & Pertti J. Neuvonen. (1998). Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations*. Clinical Pharmacology & Therapeutics. 64(2). 177–182. 225 indexed citations
14.
Lilja, Jari J., Kari T. Kivistö, & Pertti J. Neuvonen. (1998). Grapefruit juice—simvastatin interaction: Effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors*. Clinical Pharmacology & Therapeutics. 64(5). 477–483. 239 indexed citations
15.
Kivistö, Kari T., et al.. (1997). Use of Probe Drugs as Predictors of Drug Metabolism in Humans. The Journal of Clinical Pharmacology. 37(S1). 40S–48S. 68 indexed citations
16.
Laine, Kari, Kari T. Kivistö, & Pertti J. Neuvonen. (1997). Effect of Delayed Administration of Activated Charcoal on the Absorption of Conventional and Slow-Release Verapamil. Journal of Toxicology Clinical Toxicology. 35(3). 263–268. 29 indexed citations
17.
Kivistö, Kari T., Pertti J. Neuvonen, & Ulrich Klotz. (1994). Inhibition of Terfenadine Metabolism. Clinical Pharmacokinetics. 27(1). 1–5. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jari J. Lilja Breakdown of academic impact, for papers by Teemu Kantola Breakdown of academic impact, for papers by Hideki Fujino Breakdown of academic impact, for papers by Bennett Ma Breakdown of academic impact, for papers by V W Steinijans Breakdown of academic impact, for papers by Ylva Böttiger Breakdown of academic impact, for papers by T. Leemann Breakdown of academic impact, for papers by Leslie Z. Benet Breakdown of academic impact, for papers by John A. Pieper Breakdown of academic impact, for papers by Lloyd R. Whitfield
Rankless by CCL
2026